May 22, 2020 / 1:03 PM / 12 days ago

BRIEF-Medexus Provides Update On Ixinity Acquisition And Overall Business In COVID-19 Environment

May 22 (Reuters) - Medexus Pharmaceuticals Inc:

* MEDEXUS PROVIDES AN UPDATE ON THE IXINITY® ACQUISITION AND ITS OVERALL BUSINESS IN THE COVID-19 ENVIRONMENT

* MEDEXUS PHARMACEUTICALS INC - INTEGRATION OF IXINITY IS PROGRESSING IN LINE WITH EXPECTATIONS

* MEDEXUS PHARMACEUTICALS INC - CONTINUE TO GENERATE STEADY GROWTH ACROSS KEY PRODUCT LINES

* MEDEXUS PHARMACEUTICALS - NOT AWARE OF ANY DISRUPTION TO SUPPLY OF ANY OF ITS PRODUCTS TO PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below